Skip to main content

Pre-exposure Prophylaxis for People Who Use Drugs

Guest Editors:
Angela Bazzi, PhD: University of California San Diego, United States
Tyler Bartholomew, PhD:  University of Miami, United States
Hansel Tookes III, MD, MPH: University of Miami, United States

This collection is no longer accepting submissions.

Addiction Science & Clinical Practice is calling for submissions to our Collection on Pre-exposure Prophylaxis for People Who Use Drugs. People who use drugs experience increased risk of HIV acquisition from injection drug use and sexual exposures. Pre-exposure prophylaxis (PrEP) involves safe and effective medications for preventing HIV acquisition and is recommended for people with elevated injection or sexual risk. However, efforts are needed to improve PrEP delivery to people who use drugs and specific outcomes along the PrEP care continuum. 

This Collection supports and amplifies research related to SDG 3.

Image credit: Drew Neujahr

About the collection

Addiction Science & Clinical Practice is calling for submissions to our Collection on Pre-exposure Prophylaxis for People Who Use Drugs. People who use drugs experience increased risk of HIV acquisition from injection drug use and sexual exposures. Pre-exposure prophylaxis (PrEP) involves safe and effective medications for preventing HIV acquisition and is recommended for people with elevated injection or sexual risk. However, efforts are needed to improve PrEP delivery to people who use drugs and specific outcomes along the PrEP care continuum.

Addiction Science & Clinical Practice (ASCP) seeks manuscripts that address barriers and facilitators of PrEP access among people who use drugs, multilevel interventions and implementation science approaches, and novel models for improving quality of PrEP care for diverse populations impacted by substance use. The overall goal of this special series is to advance scientific understanding of PrEP for people who use drugs. Submissions may include original research, systematic reviews, meta-analyses, commentaries, and study protocols. Submissions are desired between now and September 1, 2023, and will be published in the special series upon acceptance.

Funding for the publication of a limited number of articles is available thanks to the generosity of the National Institute on Drug Abuse (NIDA). This is subject to editorial acceptance and will be offered on a first-come, first-served basis while funds are available. For further information, please contact co-series editors, Angela Bazzi, PhD, Tyler Bartholomew, PhD, and Hansel Tookes, MD, at editorial@ascpjournal.org. 

  1. Hospitalization is a “reachable moment” for people who inject drugs (PWID), but preventive care including HIV testing, prevention and treatment is rarely offered within inpatient settings.

    Authors: William Bradford, Hana Akselrod, John Bassler, Kelly W. Gagnon, Greer Burkholder, Joseph Edward Carpenter, Alaina Steck, Jillian Catalanotti, Irene Kuo, Keanan McGonigle, William Mai, Melissa Notis, Christopher Brokus, Sarah Kattakuzhy, Elana Rosenthal and Ellen F. Eaton
    Citation: Addiction Science & Clinical Practice 2024 19:22
    Content type: Letter to the Editor Published on:

  2. People who inject drugs (PWID) remain a high priority population under the federal Ending the HIV Epidemic initiative with 11% of new HIV infections attributable to injection drug use. There is a critical need...

    Authors: Tyler S. Bartholomew, Marina Plesons, David P. Serota, Elizabeth Alonso, Lisa R. Metsch, Daniel J. Feaster, Jessica Ucha, Edward Suarez Jr., David W. Forrest, Teresa A. Chueng, Katrina Ciraldo, Jimmie Brooks, Justin D. Smith, Joshua A. Barocas and Hansel E. Tookes
    Citation: Addiction Science & Clinical Practice 2024 19:21
    Content type: Study Protocol Published on:

  3. People who inject drugs (PWID) are at increased risk of HIV acquisition and often encounter barriers to accessing healthcare services. Uganda has high HIV prevalence among PWID and lacks integrated pre-exposur...

    Authors: Brenda Kamusiime, Kristin Beima-Sofie, Nok Chhun, Alisaati Nalumansi, Grace Kakoola Nalukwago, Vicent Kasiita, Chris Collins Twesige, Ritah Kansiime, Timothy R. Muwonge, Peter Kyambadde, Herbert Kadama, Peter Mudiope, Sara Glick, Barrot Lambdin, Andrew Mujugira and Renee Heffron
    Citation: Addiction Science & Clinical Practice 2024 19:13
    Content type: Research Published on:

Submission Guidelines

Back to top

This Collection welcomes submission of Research Articles, Data Notes, Case Reports, Study Protocols, and Database Articles. Before submitting your manuscript, please ensure you have read our submission guidelines. Articles for this Collection should be submitted via our submission system, Editorial Manager. During the submission process you will be asked whether you are submitting to a Collection, please select “PrEP for People Who Use Drugs” from the dropdown menu. 

Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.

The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.